We are pleased to announce that Skinive has received CE Mark clearance in the European Union. The CE marking confirms that Skinive solutions meet the
Recommended articles preview:
2nd July 2019
Now Skinive is available for independent developers in the Azure Marketplace!
We are pleased to announce that Skinive is now available on Microsoft Azure Marketplace and we became a part of Microsoft Partner Network! The Skinive team is open to collaborating with third-party solution developers at DigitalHealth and has announced the publication of its solution in the Azure cloud! Skinive.Cloud is available to third-party application developers […]
2nd June 2010
[AI Generated] What is rhinophyma?
OpenAI NN input: Rhinophyma is a skin disorder characterized by a large, red, bumpy or bulbous nose. It can occur as part of phymatous rosacea. The exact cause of rhinophyma is unknown, but it’s considered a subtype of severe rosacea. This condition is significantly more common in men, especially between the ages of 50 to […]
8th January 2022
ELISE Open Call grant funding to Skinive to develop its AI-based solution
Happy to start 2022 by announcing that Skinive has been selected to get through the ELISE AI program – EU-funded European Network of AI Excellence Centres 🎉🥇💶 Thanks Thanks to the European Horizon 2020 and ELISE AI network! Within the framework of the ELISE program, together with a network of artificial intelligence research hubs and […]